Dennis H. Honda

About Dennis H. Honda

Experienced and qualified Medical Affairs health care professional who recently joined Daiichi Sankyo as a field-based Principal Health Outcomes Liaison (HOL). Over twenty years experience in both the pharmaceutical and managed care industry. Key strengths include thought leader development in the areas of diabetes, obesity, lipids, neuroscience, psychiatry, and primary care. Extensive clinically oriented experience in health economics, pharmacoeconomics, comparative effectiveness research (CER), and outcomes research presenting to major US payers & providers. In the past has served as pharmacy director at national health plans and PBMs creating both value-driven formularies and P4P pharmacy incentive programs. Strong relationship building skills with the ability to advance his company’s clinical, scientific and research platforms to all types of audiences. Excellent leadership capabilities for customer engagement as demonstrated through best practices such as research scientist exchange programs or industry-compliant research fellowships. A team player, while performing in a matrixed environment. Acknowledged for strategic thinking, but also recognized for out-of-the box creativity nurtured by his former entrepreneurial health care experiences.

Experience

1. Principal Health Outcomes Liaison (Hol)

   Daiichi Sankyo US

   Oct 2011 — Present

   Senior Position from Oct 2011, Principal Position from 2012 to Present: Field-based HOL with responsibility for multiple(8) Western region states including California, Oregon and Washington. Health outcomes and CER expertise focused in hypertension, lipids, diabetes, and stroke•Serve as a scientific resource to national, regional US payers, ACOs, and employer coalitions providing proactive on-label, clinical, health economic & outcomes research(HEOR) data •Build relationships with value-based decision makers(VBDMs) that provide the highest return on investment, along with seeking interested investigators for potential research partnership and HEOR advisory boards•Respond to requests for unsolicited off-label information that can result in favorable access for commercial compounds•Develop and coordinate research projects with various customers in partnership with Daiichi Sankyo HEOR Department. Publish research results that align with portfolio strategies.•Provide competitive intelligence to internal stakeholders regarding the changing paradigms resulting from healthcare reform

Education

• University of California Hospitals & Clinics, San Francisco, CA.

  ASHP Accredited Clinical Pharmacy Residency

• University of California, San Francisco

  Pharm.D., Clinical Pharmacy

• California Polytechnic State University-San Luis Obispo

  Pre-Pharmacy, Engineering, Biological Sciences

Skills

• Medicine
• Market Access
• Health Economics
• Pharmacy Benefit Management
• Outcomes Research
• Drug Development
• Cardiology
• Clinical Research
• Pharmacoeconomics
• Healthcare
• Clinical Trials
• Oncology
• Infectious Diseases
• Pharmaceutical Industry
• Hypertension
• Managed Care
• Clinical Development
• Neuroscience
• Psychiatry
• Medical Affairs
• Therapeutic Areas
• Pharmacy
• Diabetes